Dr. Mary-Ann Etiebet has two decades of experience improving healthcare outcomes for vulnerable populations and transforming healthcare delivery at the frontlines. She is the Lead & Executive Director of Merck for Mothers*, Merck's $500M global health initiative to help create a world where no woman has to die giving life. Since 2011, Merck for Mothers programs and partnerships have resulted in healthy pregnancies and safe deliveries for over 11M women in 48 countries.
Building on her experiences as a physician, researcher, implementer, funder and advocate across the public, private and global development sectors, Dr. Etiebet brings a diverse set of perspectives to this work. Under her leadership, Merck for Mothers is catalyzing partnerships that leverage private sector capabilities to strengthen health systems, deliver respectful, high quality care for women, and improve maternal health outcomes. She joins Merck for Mothers from Premier Inc, where she was a Principal Consultant in the Population Health Management team. Previously, she served as Director of Ambulatory Care Strategies for New York City Health and Hospital. Her work in global health includes serving as the Senior Technical Advisor of the Institute of Human Virology-Nigeria, a PEPFAR implementing partner, while she was Assistant Professor, Division of Infectious Disease at the University of Maryland School of Medicine.
Dr. Etiebet holds an MD and MBA from Yale University. She completed her residency in Internal Medicine at New York-Presbyterian Weill Cornell and fellowship in Infectious Diseases Hospital System at New York-Presbyterian Columbia University Medical Center, becoming Board Certified in both Internal Medicine and Infectious Diseases. She is a member of the Center for Global Development Board of Directors, the UCSF Institute Health Sciences Global Health Group Advisory Board, and the Johns Hopkins Leadership Fellows program. She also serves as the private sector representative on the Partnership for Maternal, Newborn & Child Health Board and the Investors Group of the World Bank’s Global Financing Facility.
*Merck for Mothers is known as MSD for Mothers outside of the U.S. and Canada